Literature DB >> 19913809

Residual fragments after percutaneous nephrolithotomy: cost comparison of immediate second look flexible nephroscopy versus expectant management.

Jay D Raman1, Aditya Bagrodia, Karim Bensalah, Margaret S Pearle, Yair Lotan.   

Abstract

PURPOSE: We performed a cost comparison of immediate second look flexible nephroscopy vs expectant management for post-percutaneous nephrostolithotomy residual fragments.
MATERIALS AND METHODS: We used a decision analysis model to compare the cost of managing residual fragments by second look flexible nephroscopy vs observation. Outcomes of residual fragments after percutaneous nephrostolithotomy were determined from institutional experience and published shock wave lithotripsy series. Cost data were obtained from billing records. One-way sensitivity analysis was done to evaluate incurred costs of second look flexible nephroscopy while varying the likelihood of a stone event, the probability of surgery and the cost of surgical intervention. Two-way sensitivity analysis was done to assess the model across a range of scenarios.
RESULTS: Based on data in the literature and our institutional experience 40% of patients with residual fragments 4 mm or less had a stone event, of whom 57% required surgical intervention. Based on these estimates the average cost of expectant management for a residual fragment 4 mm or less vs greater than 4 was $1,743 vs $4,674. The average incremental cost of second look flexible nephroscopy at our institution was $2,475. Two-way sensitivity analysis showed that varying assumptions dramatically altered conclusions about the cost benefit of second look flexible nephroscopy.
CONCLUSIONS: Our model suggests that second look flexible nephroscopy is not cost advantageous in all patients with post-percutaneous nephrostolithotomy residual fragments. Cost benefit analysis is significantly impacted by the likelihood of a stone related event, the need for surgical intervention and surgical costs. Compared to an observational strategy second look flexible nephroscopy incurs lower costs for greater than 4 mm but not for 4 mm or less residual fragments.

Entities:  

Mesh:

Year:  2010        PMID: 19913809     DOI: 10.1016/j.juro.2009.08.135

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

1.  Longitudinal evaluation of the SF-36 quality of life questionnaire in patients with kidney stones.

Authors:  Chester J Donnally; Amit Gupta; Karim Bensalah; Altug Tuncel; Jay Raman; Margaret S Pearle; Yair Lotan
Journal:  Urol Res       Date:  2010-10-06

2.  Medium-term follow-up of clinically insignificant residual fragments after minimal invasive percutaneous nephrolithotomy: prognostic features and risk factors.

Authors:  Xin Li; Long He; Jianzhong Li; Zhongyang Duan; Zijian Gao; Long Liu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 3.  Stones in 2010: urinary tract stone disease--has therapy advanced?

Authors:  Hans-Göran Tiselius
Journal:  Nat Rev Urol       Date:  2011-02       Impact factor: 14.432

4.  The economics of stone disease.

Authors:  Noah E Canvasser; Peter Alken; Michael Lipkin; Stephen Y Nakada; Hiren S Sodha; Abdulkadir Tepeler; Yair Lotan
Journal:  World J Urol       Date:  2017-01-20       Impact factor: 4.226

5.  Postoperative morbidity of tubeless versus conventional percutaneous nephrolithotomy: a prospective comparative study.

Authors:  Fernando Marchant; Pedro Recabal; Mario I Fernández; Francisco Osorio; Javiera Benavides
Journal:  Urol Res       Date:  2011-02-20

6.  Ultrasound Guidance Reduces Percutaneous Nephrolithotomy Cost Compared to Fluoroscopy.

Authors:  Matthew Hudnall; Manint Usawachintachit; Ian Metzler; David T Tzou; Brittany Harrison; Errol Lobo; Thomas Chi
Journal:  Urology       Date:  2016-12-23       Impact factor: 2.649

7.  Place of non contrast thin-slice spiral computed tomography in evaluation of stone-free ratio after percutaneous nephrolithotomy.

Authors:  Bayram Guner; Cenk Gurbuz; Lutfi Canat; Turhan Caskurlu
Journal:  Curr Urol       Date:  2012-09-27

Review 8.  Economic Considerations in the Management of Nephrolithiasis.

Authors:  Daniel Roberson; Colin Sperling; Ankur Shah; Justin Ziemba
Journal:  Curr Urol Rep       Date:  2020-03-31       Impact factor: 3.092

9.  Impact of Residual Fragments following Endourological Treatments in Renal Stones.

Authors:  Cenk Acar; Cag Cal
Journal:  Adv Urol       Date:  2012-07-05

Review 10.  Machine learning applications to enhance patient specific care for urologic surgery.

Authors:  Patrick W Doyle; Nicholas L Kavoussi
Journal:  World J Urol       Date:  2021-05-28       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.